Development of chemical isotope labeling LC-MS for tissue metabolomics and its application for brain and liver metabolome profiling in Alzheimer's disease mouse model

Tissue metabolomics can play an important role in biological studies and biomarker discovery. However, high-coverage metabolome analysis of tissue samples remains a challenge. In this work, we report an analytical method for in-depth tissue metabolome profiling with highly accurate metabolite quanti...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Analytica chimica acta 2019-03, Vol.1050, p.95-104
Hauptverfasser: Wang, Xiaohang, Han, Wei, Yang, Jing, Westaway, David, Li, Liang
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:Tissue metabolomics can play an important role in biological studies and biomarker discovery. However, high-coverage metabolome analysis of tissue samples remains a challenge. In this work, we report an analytical method for in-depth tissue metabolome profiling with highly accurate metabolite quantification. This method is based on tissue homogenization with an extraction solvent mixture of methanol, dichloromethane and water, high-performance differential chemical isotope labeling (CIL) of metabolite extracts, followed by high-resolution liquid chromatography mass spectrometry (LC-MS) detection of labeled metabolites. The method development was initially carried out using chicken liver tissue. To demonstrate the analytical performance and potential applications of this approach in real world tissue metabolomics, we examined changes in the amine/phenol submetabolome of liver and brain tissues from an Alzheimer's disease (AD) mouse model. A total of 2319 and 1769 peak pairs or amine-/phenol-containing metabolites were commonly detected in 80% of the liver samples (n = 22) and 80% of the brain samples (n = 22), respectively. In liver samples, 89 metabolites were positively identified using labeled standard library and 1063 peak pairs were putatively matched to metabolome databases, while 78 were positively identified and 753 were putatively matched in brain samples. Using multivariate and univariate analyses to study these metabolites, we observed significant metabolome differences between AD transgenic mice and wild-type mice in both liver and brain tissues, with several metabolite biomarker candidates having good discriminative power. We envisage that the CIL LC-MS method reported herein can be used in various application areas requiring in-depth analysis of tissue metabolomes. [Display omitted] •A workflow was developed for comprehensive tissue metabolome analysis.•Dansylation isotope labeling LC-MS was used for profiling the amine/phenol submetabolome of tissue extracts.•Metabolite extraction efficiency of different solvent conditions was investigated.•Mechanical tissue disruption methods were tested and compared.•The workflow was applied for brain and liver metabolome profiling of Alzheimer's disease mouse model.
ISSN:0003-2670
1873-4324
DOI:10.1016/j.aca.2018.10.060